Outpatient terlipressin infusion for the prevention of liver events in cirrhosis
Phase 3
- Conditions
- cirrhosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12624000903583
- Lead Sponsor
- Austin Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Cirrhosis with ascites
Exclusion Criteria
Alcohol intake within 6 months
NHYA heart failure class III or IV
intrinsic renal disease eGFR <30
active cancer other than HCC within Milan
Terlipressin intolerance
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method